Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 6, 2002, Pages 1225-1227

  Hayashi, Hiroshi ^a   Kawakatsu, Shinobu ^a   Watanabe, Kyota ^a   Fukasawa, Takashi ^a   Otani, Koichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chronic renal failure; Intestinal bleeding; Neuroleptic malignant syndrome

Indexed keywords

BIPERIDEN; DANTROLENE; HALOPERIDOL; LEVOMEPROMAZINE; MIANSERIN; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; DROWSINESS; DYSARTHRIA; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HUMAN; MALE; MUSCLE RIGIDITY; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; SALIVATION DISORDER; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METHOTRIMEPRAZINE; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; RISPERIDONE;

EID: 0036775157     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00262-2     Document Type: Article

References (13)

1. Allsop P., Twigley A.J. The neuroleptic malignant syndrome. Anaesthesia. 42:1987;49-53.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. fourth ed. 1994;American Psychiatric Association, Washington, DC.
3. Converse R.L., Jacobsen T.N., Toto R.D., Jost C.M., Cosentino F., Fouad-Tarazi F., Victor R.G. Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med. 327:1992;1912-1918.
4. Dickey W. The neuroleptic malignant syndrome. Prog. Neurobiol. 36:1991;425-436.
5. Gurrera R.J. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am. J. Psychiatry. 156:1999;169-180.
6. Heykants J., Huang M.-L., Mannens G., Meuldermans W., Snoeck E., Van Beijsterveldt L., Van Peer A., Woestenborghs R. The pharmacokinetics of risperidone in humans: a summary. J. Clin. Psychiatry. 55:1994;13-17. Supplement.
7. Kunishima Y., Masumori N., Kadono M., Tsukamoto T. A case of neuroleptic malignant syndrome in a patient with hemodialysis. Int. J. Urol. 7:2000;62-64.
8. Levy N.B. Psychological problems of the patient on hemodialysis and their treatment. Psychother. Psychosom. 31:1979;260-266.
9. Marcuard S.P., Weinstock J.V. Gastrointestinal angiodysplasia in renal failure. J. Clin. Gastroenterol. 10:1988;482-484.
10. Otani K., Horiuchi M., Kondo T., Kaneko S., Fukushima Y. Is the predisposition to neuroleptic malignant syndrome genetically transmitted? Br. J. Psychiatry. 158:1991;850-853.
11. Otani K., Mihara K., Okada M., Kaneko S., Fukushima Y. Crossover reaction between haloperidol and amoxapine for NMS. Br. J. Psychiatry. 159:1991;889.
12. Otani K., Mihara K., Kondo T., Okada M., Kaneko S., Fukushima Y. Treatment of neuroleptic malignant syndrome with levodopa. Hum. Psychopharmacol. 7:1992;217-221.
13. Suzuki A., Kondo T., Otani K., Mihara K., Yasui-Furukori N., Sano A., Koshiro K., Kaneko S. Association of the TaqI A polymophism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome. Am. J. Psychiatry. 158:2001;1714-1716.